FDA adds new warning to weight loss drugs
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a higher risk of inhaling gastric contents into their lungs while under
FDA Issues New Warning For Popular Weight Loss Drugs—Here's What You Need To Know
The FDA warns GLP-1 weight loss drug users of aspiration risks during anaesthesia Learn what this update means and how to stay safe before surgeries
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Wegovy and other weight loss drugs shows promise for heart disease
A new clinical trial found that weight-loss drug Wegovy shows promise for lowering the risk of heart attack and stroke among people with heart disease and obesity.
Weight-loss drugs just got cheaper — and better
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.
Ozempic butt: A side effect of this popular diabetes and weight loss drug
Ozempic has been talk of the town for a while now, not only for helping people with diabetes, but also for working as a weight loss drug. Global celebrities like Amy Schumer, Sharon Osbourne, and Kathy Bates have admitted to using this medication to drop extra pounds.
KSL2d
Are Ozempic weight loss shots worth side effects? Do better options exist?
Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and ...
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Counterfeit weight loss drugs sold online, feeding demand for cheaper options
Real weight-loss medication pens should have unique identification codes ... Novo Nordisk, the maker of Ozempic, Rybelsus and Wegovy, said in a statement to CBS News: "It's important that ...
WebMD20h
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
MedPage Today on MSN1d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
PharmiWeb2h
Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global ...
WebMD6d
New FDA Warning Added to Popular Weight Loss Drugs
Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...
Finanznachrichten1h
Lexaria Bioscience Corp.: Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss
Lexaria is looking forward to discovering whether DehydraTECH-CBD studied alone, or together with DehydraTECH-GLP-1, in humans might offer some benefit of improved weight loss and/or reduced side ...
The Hindu5d
Has semaglutide transformed treatment of diabetes and obesity in India?
The use of the drug therefore, leads to weight loss, and some benefits to the heart and kidney have also been noted, ...